Mount Sinai School of Medicine and MRC Technology To Collaborate On Monoclonal Antibody Production and Humanization
April 03, 2012
April 3, 2012 – The Mount Sinai Medical Center and MRC Technology (MRCT), the technology transfer organization for the United Kingdom’s prestigious Medical Research Council, have reached an agreement to collaborate on the development of monoclonal antibodies that can be commercialized as …